checkAd

     157  0 Kommentare Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology - Seite 3

    For further inquiries:

    Tiziana Life Sciences Ltd
    Paul Spencer, Business Development and Investor Relations
    +44 (0) 207 495 2379
    email: info@tizianalifesciences.com

    Investors:
    Irina Koffler
    LifeSci Advisors, LLC
    646.970.4681
    ikoffler@lifesciadvisors.com

    [1] https://www.pnas.org/doi/10.1073/pnas.2220272120

    Lesen Sie auch

    [2] https://www.pnas.org/doi/10.1073/pnas.2309221120



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology - Seite 3 Oral presentation of study shows intranasal foralumab attenuates microglial activation and disease progression in multiple sclerosis (MS) patients with PIRA as measured by changes in PET scansNEW YORK, April 18, 2024 (GLOBE NEWSWIRE) - Tiziana …